• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Reduction in hospital time to thrombolytic therapy by audit of policy guidelines.

作者信息

MacCallum A G, Stafford P J, Jones C, Vincent R, Perez-Avila C, Chamberlain D A

机构信息

Department of Cardiology, Royal Sussex County Hospital, Brighton, U.K.

出版信息

Eur Heart J. 1990 Aug;11 Suppl F:48-52. doi: 10.1093/eurheartj/11.suppl_f.48.

DOI:10.1093/eurheartj/11.suppl_f.48
PMID:2226541
Abstract

Despite the importance of early thrombolysis in the treatment of acute myocardial infarction, unacceptable delays in drug administration still occur in hospital. From March 1989 we decided to monitor our performance, and thereby to reduce avoidable in-hospital delay to a minimum. Potential candidates for thrombolytic therapy were identified by paramedic ambulancemen whenever this was feasible. Rapid check-lists were used for inclusion and exclusion criteria in the Accident and Emergency Department. A target of 15 min was set for time to treatment, and reasons for any gross deviation (greater than 30 min) were explored in each instance. As a result of these strategies, we achieved a median time from admission to initiation of thrombolysis in 50 consecutive patients of 17 min. The 39 patients treated with injections of APSAC as opposed to infusions of streptokinase had a median in-hospital delay to treatment of only 13 min.

摘要

相似文献

1
Reduction in hospital time to thrombolytic therapy by audit of policy guidelines.
Eur Heart J. 1990 Aug;11 Suppl F:48-52. doi: 10.1093/eurheartj/11.suppl_f.48.
2
Delay times in the administration of thrombolytic therapy: the Brighton experience.溶栓治疗的给药延迟时间:布莱顿的经验。
Int J Cardiol. 1995 Aug;49 Suppl:S39-46. doi: 10.1016/0167-5273(95)02338-w.
3
Selection factors for the use of thrombolytic treatment in acute myocardial infarction: a population based study of current practice in the United Kingdom. The European Secondary Prevention Study Group.急性心肌梗死溶栓治疗的选择因素:基于英国当前实践的人群研究。欧洲二级预防研究小组。
Br Heart J. 1995 Sep;74(3):224-8. doi: 10.1136/hrt.74.3.224.
4
Delays in thrombolytic therapy for acute myocardial infarction in Finland. Results of a national thrombolytic therapy delay study. Finnish Hospitals' Thrombolysis Survey Group.芬兰急性心肌梗死溶栓治疗的延误情况。一项全国性溶栓治疗延误研究的结果。芬兰医院溶栓调查小组。
Eur Heart J. 1998 Jun;19(6):885-92. doi: 10.1053/euhj.1997.0866.
5
Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy.酰化纤溶酶原-链激酶激活剂复合物:溶栓治疗的新方法。
Pharmacotherapy. 1990;10(2):115-26.
6
[Prehospital thrombolytic therapy of acute myocardial infarct].急性心肌梗死的院前溶栓治疗
Herz. 1994 Dec;19(6):303-13.
7
Thrombolysis after acute myocardial infarction.急性心肌梗死后的溶栓治疗。
J Accid Emerg Med. 1997 Jan;14(1):2-9. doi: 10.1136/emj.14.1.2.
8
Thrombolytic therapy in acute myocardial infarction.急性心肌梗死的溶栓治疗
Am Fam Physician. 1992 Feb;45(2):640-8.
9
A systemic non-lytic state and local thrombolytic failure of anistreplase (anisoylated plasminogen streptokinase activator complex, APSAC) in acute myocardial infarction.急性心肌梗死中阿尼普酶(茴香酰化纤溶酶原链激酶激活剂复合物,APSAC)的全身非溶解状态及局部溶栓失败
Br Heart J. 1990 Dec;64(6):355-8. doi: 10.1136/hrt.64.6.355.
10
Survival following thrombolytic therapy.溶栓治疗后的生存率。
Eur Heart J. 1990 Aug;11 Suppl F:1-4. doi: 10.1093/eurheartj/11.suppl_f.1.

引用本文的文献

1
Operationalising routinely collected patient data in research to further the pursuit of social justice and health equity: a team-based scoping review.将常规收集的患者数据用于研究以促进社会正义和健康公平的实施:一项基于团队的范围综述。
BMC Med Res Methodol. 2025 Jan 21;25(1):14. doi: 10.1186/s12874-025-02466-9.
2
A review of interventions and system changes to improve time to reperfusion for ST-segment elevation myocardial infarction.ST 段抬高型心肌梗死再灌注时间改善的干预措施和系统变化综述。
J Gen Intern Med. 2008 Aug;23(8):1246-56. doi: 10.1007/s11606-008-0563-7. Epub 2008 May 6.
3
Prognostic implications of ventricular fibrillation in acute myocardial infarction: new strategies required for further mortality reduction.
急性心肌梗死中室颤的预后意义:进一步降低死亡率所需的新策略
Heart. 2000 Sep;84(3):258-61. doi: 10.1136/heart.84.3.258.
4
Thrombolytic therapy in acute myocardial infarction.急性心肌梗死的溶栓治疗。
Drugs Aging. 2000 Apr;16(4):301-12. doi: 10.2165/00002512-200016040-00006.
5
Health outcomes: a challenge to the status quo.健康结果:对现状的挑战。
Qual Health Care. 1992 Jun;1(2):87-8. doi: 10.1136/qshc.1.2.87.
6
Audit of thrombolysis initiated in an accident and emergency department.对在急诊科启动的溶栓治疗的审核。
Qual Health Care. 1994 Mar;3(1):29-33. doi: 10.1136/qshc.3.1.29.
7
Fax machines for thrombolysis?用于溶栓的传真机?
Heart. 1997 Aug;78(2):108. doi: 10.1136/hrt.78.2.108.
8
An evaluation of the results of media and educational campaigns designed to shorten the time taken by patients with acute myocardial infarction to decide to go to hospital.对旨在缩短急性心肌梗死患者决定前往医院所需时间的媒体和教育活动结果的评估。
Heart. 1996 Nov;76(5):430-4. doi: 10.1136/hrt.76.5.430.
9
Delays to thrombolysis in the treatment of myocardial infarction.
J R Coll Physicians Lond. 1993 Jan;27(1):19-23.
10
[Factors delaying therapy in myocardial infarct].[心肌梗死治疗延迟的因素]
Soz Praventivmed. 1993;38(2):64-70. doi: 10.1007/BF01318462.